Acupuncture for Phantom Limb Pain

Sponsor
Shaare Zedek Medical Center (Other)
Overall Status
Suspended
CT.gov ID
NCT00460161
Collaborator
(none)
40
1
2

Study Details

Study Description

Brief Summary

Phantom pain is a common complication following limb amputation, and is thought to result from a system of pathophysiological mechanisms - peripheral, spinal, central and psychological. Treatment is primarily medical, using antidepressant and anticonvulsant medications. At present, there is no evidence-based approach for the management of phantom limb pain (PLP). Acupuncture is an ancient Chinese treatment during which thin needles (diameter 0.20-0.30mm) are inserted into various points on the skin. Studies of this treatment have found significant benefit in a number of conditions with chronic pain.

We propose a randomized, double-blind, placebo/sham -controlled study to evaluate whether acupuncture is an effective and safe modality for preventing and reducing PLP in patients following lower limb amputation. Patients requiring lower limb amputation (above-ankle) will be randomized into two groups, for real or placebo/sham acupuncture treatment. Both groups will be treated twice-weekly with a standardized (as opposed to individualized) acupuncture treatment protocol, using either true or placebo needles at sham acupuncture points, for a period of four weeks (eight treatments).

The primary outcome to be evaluated will be PLP at 4 weeks, using a site-specific numerical rating pain scale (ss-NRS). Secondary outcome measures to be evaluated are: stump pain (ss-NRS); analgesic use (Tramadol, 100mg Tablet); and depressive symptoms, using the Beck Depression Score. Blinding of the participants will be evaluated using a Validation of Blinding Questionnaire at the end of the treatment period.

Condition or Disease Intervention/Treatment Phase
  • Procedure: acupuncture
  • Other: placebo/sham acupuncture
Phase 3

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Acupuncture for Phantom Limb Pain: A Randomized, Double-Blind, Placebo/Sham - Controlled Study
Study Start Date :
Feb 1, 2009
Anticipated Primary Completion Date :
Aug 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 1

true acupuncture

Procedure: acupuncture
2 treatments/week for 4 weeks

Placebo Comparator: 2

placebo/sham acupuncture

Other: placebo/sham acupuncture
2 treatments/week for 4 weeks

Outcome Measures

Primary Outcome Measures

  1. To study the effect of acupuncture on phantom limb pain at 4 weeks post-amputation [4 weeks]

Secondary Outcome Measures

  1. To study the effect of acupuncture on phantom limb pain at 3 months post-amputation [3 months]

  2. To study the effect of acupuncture on stump pain at 4 weeks post-amputation [4 weeks]

  3. To study the effect of acupuncture on analgesic use (Tramadol 100mg) during the first 4 weeks post-amputation [4 weeks]

  4. To study the effect of acupuncture on parameters of depression (using the Beck Depression Score) at 4 weeks and 3 months post-amputation [4 weeks and 3 months]

  5. To study the safety of acupuncture treatment in patients following amputation with phantom limb pain [4 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients of either gender

  • Age 18 years and older

  • Scheduled for lower single limb amputation (above or below knee)

  • Ability to comply with study protocol

Exclusion Criteria:
  • Patients requiring limb amputation due to trauma

  • Patients displaying symptoms of overt Axis-1 psychopathology such as Schizophrenia or Substance Abuse

  • Inability to comply with the study protocol

  • Previous experience with acupuncture treatment; current use of complementary or alternative medical treatments.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Shaare Zedek Medical Center Jerusalem Israel 91031

Sponsors and Collaborators

  • Shaare Zedek Medical Center

Investigators

  • Principal Investigator: Noah Samuels, M.D., Shaare Zedek Medical Center, Jerusalem, Israel

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00460161
Other Study ID Numbers:
  • ACP.PLP.10.06
First Posted:
Apr 13, 2007
Last Update Posted:
Feb 18, 2009
Last Verified:
Aug 1, 2008
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 18, 2009